ERIK KAVANAGH: Open Payments
NPI 1740862119 · WACO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$985 in 33 payments from 5 companies in 2025. Trend: 2023 $157 · 2024 $714 · 2025 $985
Food & beverage: $985
| Company | Payments | Amount |
|---|---|---|
| Averitas Pharma Inc. | 9 | $449 |
| ABBVIE INC. | 16 | $332 |
| Medtronic, Inc. | 5 | $96 |
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $54 |
| Boston Scientific Corporation | 1 | $52 |
Products named: QUTENZA, BOTOX, QULIPTA, INTELLIS ADAPTIVESTIM, JOURNAVX, General - Pain Management, INCEPTIV, UBRELVY.
Industry payments across TX — which companies pay providers there.
